171 Followers on Owler

Altravax

is engaged in the discovery and development of vaccines for infectious diseases... Read more
OverviewCompetitorsFundingNews & Insights

Altravax

is engaged in the discovery and development of vaccines for infectious diseases... Read more
Altravax Interim-CEO: Michael Chambers

Interim-CEO

Michael Chambers

CEO Approval Rating

70/100

2009

PrivateIndependent Company

Pharmaceuticals & Biotechnology
BiotechnologyPharmaceuticals
28362834 NAICS listing

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Contacts
New
Schedule a Demo
Funding
$2M

News

Jul 13, 2016
Business Wire
Press Release: Altravax : Dengue Fever Therapeutics Pipeline Review, H1 2016 Edition - Research and Markets
May 27, 2016
Business Wire
Press Release: Altravax : Global Equine Encephalitis Report 2016 - Therapeutics Pipeline Review of 6 Companies & Their Drug Profiles - Research and Markets
Apr 01, 2016
NewsMaker
Press Release: Altravax : Influenza B Infections Therapeutics & Drugs Pipeline Review, H1 2016
Oct 23, 2015
BUSINESS WIRE
Press Release: Altravax : Research and Markets: Western Equine Encephalitis Pipeline Review, H2 2015 - 5 Companies & 3 Drug Profiles
Sep 23, 2015
BUSINESS WIRE
Press Release: Altravax : Research and Markets: Eastern Equine Encephalitis - Pipeline Review, H2 2015 - 4 Companies & 1 Drug Profile
Sep 02, 2015
BUSINESS WIRE
Press Release: Altravax : Research and Markets: Dengue Therapeutics Pipeline Review, H2 2015 - 37 Companies & 80 Drug Profiles
Jun 22, 2015
BUSINESS WIRE
Press Release: Altravax : Research and Markets: Seasonal Influenza Therapeutics Pipeline Review, H1 2015
Jun 09, 2015
BUSINESS WIRE
Press Release: Altravax : Research and Markets: Eastern Equine Encephalitis - Pipeline Review, H1 2015
May 27, 2015
PR-INSIDE.COM
Press Release: Altravax : New Market Report: AltraVax Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
May 20, 2015
PRSYNC
Press Release: Altravax : AltraVax Inc. - Product Pipeline Review - Market Research Report 2015

Altravax Competitors

1
2
3
4
5
6
7
8
9
10
Unlock 16 + competitors

Looking for similar companies to Altravax?

Similar Companies

Pharmaceuticals companies in Sunnyvale

See 10 companies 
Pharmaceuticals companies in San Francisco Bay Area

See 317 companies 
Pharmaceuticals & Biotechnology companies in Sunnyvale

See 20 companies 
Biotechnology companies in Sunnyvale

See 18 companies 
Companies in Sunnyvale with employees in 1-25 range

See 393 companies 
Biotechnology companies in San Francisco Bay Area

See 693 companies 
Pharmaceuticals companies in California

See 779 companies 
Pharmaceuticals & Biotechnology companies in San Francisco Bay Area

See 861 companies 
Companies in Sunnyvale with revenue in $100K-5.0M range

See 1,401 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Altravax Press Releases

Altravax's News
July 13, 2016Business Wire

Dengue Fever Therapeutics Pipeline Review, H1 2016 Edition - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Dengue Fever - Pipel... See more »
Altravax's News
May 27, 2016Business Wire

Global Equine Encephalitis Report 2016 - Therapeutics Pipeline Review of 6 Companies & Their Drug Profiles - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Equine Encephalitis ... See more »
Altravax's News
April 1, 2016NewsMaker

Influenza B Infections Therapeutics & Drugs Pipeline Review, H1 2016

WiseGuyReports.com adds"Influenza B Infections Therapeutics & Drugs Pipeline Review, H1 2016"reports ... See more »

Altravax Headquarters

725 San Aleso Ave Suite 2

Sunnyvale, California94085

1-888-710-9203

Driving Directions »

Altravax Summary

ABOUT

Overview

Altravax is engaged in the discovery and development of vaccines for infectious diseases. Altravax was founded in 2009. Altravax's headquarters is located in Sunnyvale, California, USA 94085. Altravax's Interim-CEO, Michael Chambers, currently has an...

CEO

Altravax's Interim-CEO, Michael Chambers, currently has an approval rating of 70%. Altravax's primary competitors are Dynavax, GlobeImmune, Agenus and 16 more.

Website

altravax.com

Competitors

View 19 Altravax competitors here.

Acquisitions

There have been no acquisitions found related to Altravax

Funding

View Altravax funding details.

Investments

Recent investment data cannot be found related to Altravax

Frequently Asked Questions about Altravax

  1. When was Altravax founded?

    Altravax was founded in 2009

  2. Who is Altravax's CEO?

    Altravax's CEO is Michael Chambers

  3. How much revenue does Altravax generate?

    Altravax generates $2M in revenue

  4. How much funding does Altravax have?

    Altravax has historically raised $2M in funding

  1. Where is Altravax's headquarters?

    Altravax's headquarters is in Sunnyvale California, USA

  2. How many employees does Altravax have?

    Altravax has 10 employees

  3. What sector does Altravax operate in?

    Altravax is in Biotechnology, Pharmaceuticals

  4. Who are Altravax's competitors?

    Altravax's top competitors are Dynavax, GlobeImmune, Agenus
Stay up-to-date with the latest news on Altravax

Trending Companies